
Dr. Cynthia (Cindy) Dunbar is a physician-scientist and hematologist focused on acquired and inherited bone marrow failure, ITP, stem cell mobilization, transplantation and cell and gene therapies. In the laboratory she studies hematopoiesis and stem cell clonality, natural killer biology and works to improve the safety and effectiveness of gene therapy and gene editing technologies for modification of hematopoietic and immune cells. She serves as Chief of the Translational Stem Cell Biology Branch and NIH Distinguished Investigator within the intramural program of the National Heart, Lung, and Blood Institute at the National Institutes of Health in Bethesda, MD. Dr. Dunbar earned her MD from Harvard Medical School and her BA from Harvard University in History and Science. She has authored over 300 peer-reviewed publications, and is an elected member of the National Academy of Medicine. Her leadership roles include current President-Elect and past Secretary and Councilor of the American Society of Hematology, past President of the American Society of Gene and Cell Therapy, Editor-in-Chief of Blood, and Founder and Chair of the NIH Assembly of Scientists. She received the ASH Public Service Award for leadership during the COVID-19 pandemic.
Postdoctoral fellow
1987 – 1993
Medical School
1980 – 1984
Residency
Fellowship